Additionally, mineralocorticoid receptors (MRs), which are abundant in critical brain regions like the hippocampus, an area essential for memory and highly affected in Alzheimer’s disease, may serve as targets for spironolactone’s cognitive effects [6]. The gene discussed is NR3C2; the disease is early-onset autosomal dominant Alzheimer disease.